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Key messages 
 
What is already known about this subject? 
Children with congenital heart disease risk difficulties in academic and daily life functioning, 
which are linked to intelligence and specific neurocognitive skills such as executive functions, 
attention and memory.  
What does this study add? 
This meta-analysis demonstrates that children with congenital heart disease who underwent 
heart surgery, show impairment in basic alertness, which is essential for intellectual, executive 
and academic functioning. 
How might this impact on clinical practice? 
Physicians need to be aware that additional testing for alertness may be helpful for children 
with CHD who experience subtle, but pervasive difficulties in daily and academic 
functioning,  
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Abstract  
 
Background and objective: Children with congenital heart disease (CHD) often experience 
difficulties in academic and daily functioning, which have been associated with intelligence 
and neurocognitive skills, like executive functions (EFs), attention and memory. We report 
the neurocognitive data of children with CHD who were included in the Leuven glucose 
control trial (LGC-trial). Through a systematic review and meta-analysis, we aimed to find 
which neurocognitive functions are most consistently and prominently affected.  
Methods: 365 children with CHD and 216 healthy control children underwent extensive 
neurocognitive testing in the LGC-trial. A comprehensive search of electronic databases 
PubMed, Embase and Cochrane was conducted for studies measuring intelligence, EFs, 
attention and memory in children who underwent heart surgery for CHD. Standardized mean 
differences (SMDs) between the CHD-group and a healthy control group were calculated for 
these neurocognitive functions. LGC-trial data were included in the meta-analysis.   
Results: 12 studies with a healthy control group were included in the meta-analysis, involving 
647 CHD-patients and 633 controls. The CHD-group (median age 7.35 years at testing) 
scored worse than healthy control children for all investigated neurocognitive functions. A 
medium SMD was found for intelligence (SMD=-0.53 [95% CI: -0.68 to -0.38] p<0.00001). 
Alertness, an attentional function, was also consistently poorer in the CHD-group. Memory 
was less affected, while EF had a medium SMD with large heterogeneity.  
Conclusions: Children with CHD risk lower performance on intelligence and alertness, which 
may contribute to daily life and school difficulties. Heterogeneity in neurocognitive 
assessment and small sizes in most studies limit the interpretation.  
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Introduction 
As the survival rate of children with congenital heart disease (CHD) continues to improve 
thanks to medical advances,1 public interest and research have been focusing more on how 
children with CHD survive.2 Children with CHD may experience difficulties in daily3 and 
academic functioning4, which may persist into adulthood.5 In this systematic review and 
meta-analysis we aim to examine intelligence and specific neurocognitive skills, especially 
executive functions, as important predictors for academic and daily functioning in children 
with CHD after heart surgery. 
Intelligence scores (IQ) are a good predictor of academic performance.6 However, children 
with CHD often have intelligence scores within average range compared to population 
norms.7 Research in other pediatric conditions, such as traumatic brain injury, has 
demonstrated that intelligence scores are rough measures, which fall short to detect more 
specific neurocognitive skills like executive functions (EFs).8 EFs cover a variety of cognitive 
functions, such as planning, organization, flexibility, cognitive control and working memory. 
These are essential in many domains of daily life9 and contribute to academic 
performance.10,11 Other neurocognitive skills like memory and attention, which are 
interrelated with EFs, also contribute to academic performance. 9  
There is growing evidence that brain development of children with CHD can differ from 
normal brain development. This misdevelopment may even start prenatally due to impaired 
cerebral blood flow.12 Postnatally, infants and older children with CHD may have 
preoperative13 and postoperative white matter abnormalities,14 which may relate to worse 
neurocognitive outcome in children with CHD.15 Surgery seems to impact neurocognitive 
outcome in CHD as well.15 Considering the vulnerability of their brain, neurocognitive 
functions may be worse in children with CHD than in healthy control children without CHD. 
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Some relevant reviews have discussed the importance of these neurocognitive functions.2,16,17 
However, to our knowledge, the outcome data of specific neurocognitive functions have not 
been analyzed systematically in children with CHD. One systematic review18 and one meta-
analysis19 examined intellectual outcome but not more specific neurocognitive skills in 
children with CHD after heart surgery.  
A large randomized controlled trial (n=700) in which neurocognitive development of children 
was assessed 4 years after critical illness and treatment with tight glucose control has recently 
been completed.20 The results demonstrated that tight glucose control in critically ill children 
improved motor coordination and cognitive flexibility in comparison with children in whom 
blood glucose levels up to 215 mg/dL were tolerated.20 Seventy-five % of the study 
population in this Leuven glucose trial (LGC-trial) underwent heart surgery for congenital 
heart defects. Neurocognitive data of the heart surgery subgroup have not been analyzed yet. 
Thus, the first aim of this paper was to report the neurocognitive data of this large cohort of 
children with heart surgery for CHD, included in the LGC-trial, and healthy controls. The 
second aim was to do a systematic review and meta-analysis for intelligence, EFs, attention 
and memory in children with CHD after heart surgery. We hypothesized that specific 
neurocognitive skills like EFs are more impaired than intelligence in children with CHD.  
   6 
 
Methods 
1) Analysis of the LGC-trial data 
Data of all children who underwent neurocognitive testing and for whom a full-scale IQ was 
available, were analyzed (children with CHD n=361, healthy controls n=215). For four 
children of the CHD-group and one child of the control group, a full-scale IQ could not be 
calculated. Baseline neurocognitive data, when the patients were included into the LGC-trial, 
were not available. Demographic, clinical and neurocognitive data are reported as numbers 
and percentages, or, median and interquartile range (IQR). Because of imbalance between the 
CHD- and control group for gender, the presence of a syndrome, socio-economic status and 
age at follow-up, propensity score matching was performed using IBM SPSS Statistics 
22.0.0.1 and R statistical software version 2.15.3. For more details on propensity score 
matching, we refer to eMethods1. Demographic, clinical and neurocognitive data of the 
tested and matched population were further analyzed using chi-square test for dichotomous 
variables and unpaired non-parametric Wilcoxon rank-sum tests for continuous variables 
(JMP version 11.2.0 [SAS Institute]). The details of the study protocol and neurocognitive test 
battery have previously been reported.20  
 
2) Systematic review & meta-analysis 
Data sources and searches 
A comprehensive search of electronic databases PubMed, Embase and Cochrane was 
conducted for studies published between the beginning of each database and December 2014. 
Each search strategy consisted of four major parts: cognition, heart, child and tests. Both 
index language terms (MeSH, Emtree) and keywords were used in every part of the search 
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strategy (See eMethods 2). We also manually screened reference lists of studies identified 
through database search. 
Study selection 
Two selection criteria were premised for title and abstract screening. First, the study 
population consisted of infants, children, adolescents and/or young adults (<24 years old) with 
CHD. Second, they needed to have at least an intelligence testing with an indication of a 
specific measure of EF, memory or attention, or broader neurocognitive assessment. For the 
full-text screening we introduced two more selection criteria. First, the subjects had 
neurocognitive testing after heart surgery or an interventional cardiac procedure. Studies that 
tested subjects in the first six postoperative months were excluded to avoid interference with 
the acute medical phase. Second, at least one test that measured EF, memory and/or attention 
was needed.  
 
Data extraction  
First, we gathered data about the sample size, the age at surgery and the age at testing of the 
tested groups. We also investigated whether the same study population was tested in already 
included studies of the same research group. Furthermore, for the comparison of the CHD-
group versus a healthy control group, we collected data necessary to quantify differences 
between the CHD- and healthy control group. The collected data are summarized in Table 1. 
In case of missing data for the quantitative analysis, authors were contacted.  
 
Data analysis  
As appropriate, mean (standard deviation) or median (interquartile range) sample size, age at 
surgery and age at testing were calculated for all studies. Risk of bias of all included studies 
20-31 was assessed by two raters independently (CS and JL) by means of a modified version of 
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the Downs and Black checklist.32 Six items that focus on RCT’s (items 4, 8, 14, 19, 23, 24), 
were omitted, leading to a maximum total score of 22. In case of different scores by the two 
raters a consensus was reached through discussion. Inter-rater reliability was good 
(Spearman’s Rho 0.722; p=0.008). Depending on the number of included studies, mean 
(standard deviation) or median (interquartile range) total risk of bias and sub-scores were 
calculated for all studies. 
Analyses were performed on neurocognitive data of studies that used a healthy control group. 
To combine these continuous data measured by different instruments, effect sizes, i.e. 
standardized mean differences (SMDs), were calculated in Review Manager 5.2 by means of 
Inverse Variance, random effects analysis (http://ims.cochrane.org/revman). SMDs were 
calculated for the following neurocognitive functions: intelligence, alertness (attentional 
function), memory, and inhibition (executive function). Neurocognitive data of the LGC-trial 
were included in the SMD-calculation. A two-sided p-value <0.05 was considered statistically 
significant. SMDs were classified according to Cohen’s guidelines: d = 0.2 defined as small, d 
= 0.5 as medium and d = 0.8 as large.33 For clinical interpretation, the overall SMD for 
intelligence scores was multiplied by the typical standard deviation (SD) of the normal IQ 
distribution (mean 100 ± SD 15). The I²-statistic was used to evaluate heterogeneity. I² ≥ 50% 
was defined as substantial heterogeneity. Funnel plots were also made in Review Manager, 
when at least 10 studies were available, to explore small-study effects.  
For more details on study selection and data analysis we refer to eMethods 1.  
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Results 
1) Analysis of the LGC-trial data 
Demographic and clinical data of tested and matched post-heart surgery population and 
healthy controls are presented in Table 2. Neurocognitive data are presented in Table 3. 
Children of the tested post-heart surgery population score worse for intelligence, visual-motor 
integration and all measures of alertness, motor coordination, inhibition, flexibility (except for 
∆No. of errors), memory and behavior, compared to healthy controls. After propensity score 
matching, the CHD-group scores worse for intelligence, visual-motor integration, motor 
coordination (alternating taps), inhibition (∆ No. of errors), memory (verbal working memory 
and immediate memory) and behavior (internalizing and total problems).  
 
2) Systematic review & meta-analysis 
Flow diagram 
Figure 1 shows the article screening phases and the reasons for exclusion, according to the 
PRISMA guidelines (Preferred Reporting Items for Systematic Reviews and Meta-analysis).34  
An overview of the 12 included studies is presented in eTable 1. 
 
Sample size, age at surgery and at testing 
The median sample size of the CHD-groups in all 12 studies that were included in the meta-
analysis was 31 (IQR 18-43) The median sample size of the healthy control groups was 33 
(IQR 20-42). The median age at surgery was 1.25 years (y) (IQR 0.0.7-3.85y) and the median 
age at testing was 7.35 y (IQR 5.70-8.37).  
 
Quality assessment 
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The median (interquartile range, IQR) risk of bias of all 12 included studies was 16 (IQR 15-
17). Median score for reporting was 8 (IQR 7-8) with a maximum score of 9. Median score 
for external validity was 2 (IQR 1-2) with a maximum score of 3 and median score for 
internal validity was 7 (IQR 5-7) with a maximum score of 9. Only 1 out of 12 studies 
mentioned that the study had sufficient power to detect a clinically relevant difference.  
 
Meta-analyses: CHD-group versus healthy controls 
Total SMDs for all neurocognitive domains indicate lower scores for the CHD-group. A 
medium SMD with low heterogeneity was found for intelligence (SMD=-0.53 [95% CI: -0.68 
to -0.38] p<0.00001, I2=32%) (Figure 2), indicating a drop of 0.53 times the standard 
deviation of the normal IQ distribution: -8 IQ points. A medium SMD was also found for 
alertness non-reaction time (SMD=-0.47 [95% CI: -0.67 to -0.27] p<0.00001, I2=19%) 
(Figure 3) and a smaller SMD for alertness reaction time (SMD=0.25 [95% CI: 0.08 to 0.42] 
p=0.004, I2=0%) (eFigure 1). Verbal memory showed a smaller SMD (SMD=-0.35 [95% CI: 
-0.54 to -0.15] p=0.0004, I²=0%) (Figure 4), while  non-verbal memory did not differ 
between children with CHD and healthy controls (eFigure 2). EF reaction time, examining 
the inhibition function, had the largest SMD, but a high level of heterogeneity (SMD=0.57 
[95% CI: 0.10 to 1.04] p=0.02, I²=80%) (Figure 5). EF non-reaction time for inhibition also 
showed a medium SMD but with low heterogeneity (SMD=-0.51 [95% CI: -0.74 to -0.29] 
p<0.00001, I²=0%) (eFigure 3). The funnel plot for intelligence was slightly asymmetrical 
(eFigure 4). Due to the limited availability of studies on the other neurocognitive functions, 
funnel plots could not be built for alertness, memory and inhibition. 
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Discussion 
This meta-analysis and the results of the LGC-trial provide sound evidence that not only 
intelligence but also more specific neurocognitive functions are impaired in children with 
CHD who underwent heart surgery, compared with healthy controls. Contrary to our 
hypothesis, intelligence, EFs and alertness seem to be equally affected. 
 
Intelligence 
The SMD of -0.53 (95% CI -0.68, -0.38) in the meta-analysis and the effect size of 8 IQ-
points in both the meta-analysis and LGC-trial are of similar magnitude to these in 
prematurely born children35 and are in line with the meta-analysis of Karsdorp et al.19 Despite 
the worse intelligence scores for the CHD-group compared to healthy controls, the mean IQ 
scores of the children with CHD were still within the “normal” average range, when 
comparing with population norms. Nevertheless, these IQ differences can have consequences 
in a learning environment.36 Population norms might insufficiently capture the dynamic 
nature of development. A well-matched healthy control group of typically developing 
children without CHD may offer a more representative reflection of normal variation between 
and within typically developing children37,38 who grow up in the same time period as children 
with CHD.  
 
Alertness, inhibition and memory  
Similarly to intelligence, alertness was also consistently impaired across the available studies 
in the meta-analysis. The alerting system is one of the attentional networks in addition to the 
orienting and executive attention network.39 It is responsible for achieving and maintaining a 
state of high sensititivity to incoming information. An efficient alerting system is pivotal for 
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other more complex cognitive functions, such as EF. Additionally, detecting problems of 
alertness has an important clinical consequence because improving alertness is considered 
essential for cognitive rehabilitation.  
Recently, more consideration is given to impairments in EF in children with CHD.2,16,17 The 
LGC-trial showed that in critically ill children exactly the more complex EF, flexibility, was 
improved by tight glucose control, almost to the levels of healthy controls20 However, from 
this meta-analysis we have to conclude that studies examining these specific neurocognitive 
skills are scarce. The few studies included in this meta-analysis involved several specific 
subgroups of CHD with only a limited number of patients in each subgroup. This resulted in 
low statistical power and precision. Also the use of different tests for EF, adding to the 
ascertained heterogeneity, may have had an impact on low precision.  
Nevertheless, the SMD (0.57) for EF reaction time was in line with the deficit in intelligence 
(0.53). It indicates that children with CHD react slower when performing specific EF-tasks 
measuring inhibition. Children with CHD from the LGC-trial showed the smallest SMD in EF 
reaction time.20 This may be attributed to the larger size of the study and to the fact that the 
EF reaction time was corrected for baseline speed and the propensity score matching. The 
CHD-group of the LGC-trial also made more errors during an inhibition test. This meta-
analysis confirmed the findings from previous reviews2,16,17 that the risk of memory deficits in 
children with CHD may be lower. However, results from the LGC-trial showed worse 
performance for immediate memory and working memory of verbal information in the CHD-
group. The use of pooled memory scores in the meta-analysis may have hidden specific 
memory deficits. Children may also have been too young to detect differences in tests, which 
are examining functions that are continuously developing through childhood.   
The aforementioned indicates that the difficulties, which children with CHD experience when 
performing IQ-tests and complex tasks requiring EFs, may be explained by a basic alertness 
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deficit. This has also been found in other pediatric populations and may be linked with white 
matter changes.40 Alternatively, other EFs like flexibility20 or working memory may 
preferentially be affected.  
 
Strenghts 
This systematic review and meta-analysis has several strengths. Exploring the effects of CHD 
on not only intelligence but also EFs, attention and memory in the same patients has been a 
new avenue in the assessment of neurocognitive function in children with CHD. This allowed 
us to compare the impact of CHD on intelligence with the impact of CHD on specific 
neurocognitive skills. The studies which included a healthy control group could be combined 
for the analysis of a SMD, despite the use of different tests. Therefore, the findings are fairly 
robust. The analysis of the LGC-trial data offers a valuable contribution of neurocognitive 
data of a large CHD- and healthy control group, thereby increasing power and precision in the 
meta-analysis. Certainly, propensity score matching for relevant factors in neurocognitive 
development improved the stringency and reliability of the analyses.  
 
Limitations 
The meta-analysis has a few inherent limitations though. First, attention and EFs involve 
several functions, which may interact.9 Although the lower aggregated score on intelligence is 
clinically relevant, it is not clear whether the poorer results for attention and EF have any 
clinical impact, because universal definitions and test protocols are lacking. Unfortunately, 
the number of studies assessing different aspects of attention and EF was scarce. As a result, 
only one attentional function and one EF could be examined in this meta-analysis. Therefore, 
no conclusions can be drawn for other attention components and EFs. Future studies thus 
ought to use comparable test batteries for neurocognitive function assessments. Second, the 
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very small sample sizes of the CHD- and control groups, partially due to the separate 
reporting of a high variation in CHD diagnoses, reduced statistical power and precision both 
at the individual study level and at meta-analysis level. Because of the separate reporting of 
CHD-subgroups, neurocognitive data of healthy controls were sometimes included twice in 
forest plots. The slightly asymmetrical funnel plot of intelligence reflects a possible 
publication bias and may have overestimated the effect size. Future research should pay more 
attention to the statistical powering of effects on neurocognitive outcome. Third, the exclusion 
of six non-English studies (one Italian, one Chinese, one French, one Spanish and two 
German) might have raised a language bias. However, research has shown no evidence of 
systematic bias from the use of language restrictions in systematic review-based meta-
analyses.41 Third, this meta-analysis cannot draw any conclusion on the interaction between 
effect of IQ and alertness, EF, and memory. At least to exclude that effects on EFs and 
memory are not entirely explained by a generalized or more basic impairment, one ought to 
examine IQ and alertness in addition to the other functions. Fourth, studies on EFs, attention 
and memory outcome in adolescence are lacking, indicating the need for long-term 
longitudinal follow-up studies up to secondary education,18 when academic difficulties can 
appear. Adolescence is particularly essential for the late maturation of the prefrontal cortex 
and EFs.37 Understanding the impact of these prefrontal cortex functions on daily and school 
functioning is clinically relevant, because a better understanding and early detection of 
deficits may improve daily functioning of children with CHD.2 
 
Conclusions 
Children with CHD who underwent heart surgery, consistently perform worse for intelligence 
and alertness. Memory appears to be less affected from this meta-analysis. The effect of CHD 
on EF in young children cannot be reliably assessed due to poor standardization of the testing 
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methodology. Larger, more standardized, longitudinal long-term follow-up studies of specific 
neurocognitive skills in a large group of children with CHD and a matched healthy control 
group, are necessary for a better understanding of neurocognitive deficits and their impact on 
daily life and school functioning. 
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Tables 
Table 1. Data collected for quantitative analysis 
CHD-group: type of CHD, sample size 
Control group: type of control group, sample size 
Age surgery, age testing 
Overlap study population with another included study of the same research group: 
yes/no and if yes, decision (inclusion/exclusion)  
Intelligence: name of test(s), intelligence scores (mean, SD) of CHD- and healthy control 
group 
Memory: name of test(s), memory scores (mean, SD) of CHD- and healthy control group 
Attention: name of test(s),  attention scores (mean, SD) of CHD- and healthy control group 
Executive functions: name of test(s), executive function scores (mean, SD) of CHD- and 
healthy control group 
 
Abbreviations: SD = standard deviation 
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Table 2: Demographic and clinical data of tested and propensity score matched post-
heart surgery population and healthy controls in the LGC-trial 
 
Tested population Propensity score matched population 
 Tested-Post-
Heart surgery 
population 
(N=361) 
Healthy controls 
 
 
 (N=215) 
p-value Tested-Post-
Heart surgery 
population 
(N=167) 
Healthy controls 
 
 
 (N=167) 
p-value 
Caucasian race1 343 (95.01) 211 (98.14) 0.058 162 (97.01) 164 (98.20) 0.474 
Exclusive European1 330 (91.41) 201 (93.49) 0.369 160 (95.81) 156 (93.41) 0.332 
Exclusive Dutch language1 296 (81.99) 186 (86.51) 0.155 144 (86.23) 142 (85.03) 0.755 
Male sex1 205 (56.79) 93 (43.26) 0.001 81 (48.50) 81 (48.50) 1.000 
Age at randomization, years2 0.76 (0.22-4.1) NA NA 2.11 (0.34-4.77) NA NA 
Type of congenital heart disease1   
 
  
  
  
    Obstructive pathology 79 (21.88) NA NA 37 (22.15) NA NA 
    Left-right shunt 121 (33.51) NA NA 60 (35.92) NA NA 
    Cyanotic & not-univentricular 122 (33.79) NA NA 59 (35.32) NA NA 
    Cyanotic & univentricular 70 (19.39) NA NA 27 (16.16) NA NA 
    Other 11 (3.04) NA NA 5 (2.99) NA NA 
RACHS-classification1   
 
  
  
  
    1 or 2 168 (47.72) NA NA 79 (48.17) NA NA 
    3 or 4 175 (49.71) NA NA 84 (51.21) NA NA 
    6 9 (2.55) NA NA 1 (0.60) NA NA 
Syndrome, at randomization1 69 (19.11) 16 (7.44) <0.001 20 (11.98) 16 (9.58) 0.480 
PELOD first 24h in ICU2 11 (2-12) NA NA 11 (2-12) NA NA 
Socio-economic status score† 35 (24-48.5) 42.5 (29-54) <0.001 39.5 (29-50) 39.5 (29-52.5) 0.455 
At follow-up2   
 
  
  
  
    Height, cm 107 (103-126) 122 (108-151) <0.001 116 (104-131) 117 (107-139) 0.069 
    Weight, kg 18 (15-24) 22 (18-40) <0.001 20 (16-29) 21 (18-34) 0.072 
    Head circumference, cm 50.7 (49.2-52.5) 52 (50.8-54) <0.001 51 (49.5-53) 51.8 (50.5-53.4) 0.001 
    Age, y 4.67 (4.14-7.93) 6.75 (4.68-11.56) <0.001 6.02 (4.21-8.78) 5.91 (4.58-9.07) 0.359 
 
1numbers and percentages; 2median (interquartile range, IQR) 
Abbreviations: NA = not applicable; RACHS = Risk adjustment for congenital heart 
surgery42; PELOD = pediatric logistic organ dysfunction43 
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Table 3: Results of neurocognitive test battery in tested and propensity score matched 
post-heart surgery population and healthy controls in the LGC-trial 
 
Tested population Propensity score matched population 
  Tested-Post-
Cardiac surgery 
population  
(N=361) 
Healthy controls  
 
 
(N=215) 
p-value Tested-Post-
Cardiac surgery 
population  
(N=167) 
Healthy controls  
 
 
(N=167) 
p-value 
Clinical neurological evaluation score 
(range, 0-8)1 
1 (0-2) 0 (0-1) <0.001 1 (0-2) 0 (0-1) <0.001 
Intelligence (range of possible scores, 
45-155)2 
      
-Full-Scale IQ 90 (75-100) 103 (91-111) <0.001 92 (78-103) 101 (90-110) <0.001 
-Verbal IQ 90.5 (76.2-101) 102 (92-114) <0.001 94 (79.5-104) 101 (91-112) <0.001 
-Performance IQ 89 (77-101) 103 (92-112) <0.001 91 (77-102) 101 (89-112) <0.001 
Visual-Motor Integration (range, 0.9-20)2 9 (7-10) 10 (8-12) <0.001 9 (7-10) 10 (9-12) <0.001 
Attention, motor coordination and 
executive functions 
      
-Alertness1       
   Reaction time dominant hand, msec 691 (447-982) 481 (320-700) <0.001 566 (374-829) 544 (365-749) 0.345 
   Within-patient SD of repeated tests 404 (143-642) 165 (83-383) <0.001 228 (115-535) 190 (98-433) 0.075 
   Reaction time nondominant hand, msec 697 (436-968) 499 (326-721) <0.001 543 (374-791) 542 (375-744) 0.677 
   Within-patient SD of repeated tests 336 (158-611) 192 (87-379) <0.001 221 (110-482) 216 (105-412) 0.410 
-Motor coordination (No. of taps in 10s)2       
   No. of unimanual taps dominant hand 28 (22-38) 35 (25-46) <0.001 31 (22-42) 32 (24-43) 0.346 
   No. of unimanual taps nondominant hand 23 (17-33) 29 (21-43) <0.001 25 (18-35) 27 (20-38) 0.117 
   No. of valid alternating taps 8 (2-18) 13 (5-30) <0.001 8 (2-20) 11 (5-26) 0.039 
   No. of valid synchronous taps 16 (8-24) 21 (12-31) <0.001 18 (11-27) 19 (11-27) 0.768 
-Inhibition and flexibility1       
   ∆ Reaction time (inhibition), msec 313 (120-536) 200 (79-485) 0.008 261 (98.7-438) 258 (94-500) 0.876 
   ∆ No. of errors (inhibition) 2 (0-3) 1 (0-2) 0.002 1.5 (0-3) 1 (0-2) 0.038 
   ∆ Reaction time (flexibility), msec 637 (367-878) 550 (283-798) 0.043 603 (330-848) 623 (345-869) 0.726 
   ∆ No. of errors (flexibility) 2 (0-4) 1 (0-3) 0.243 2 (0-4) 1 (0-3) 0.104 
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Table 3: Results of neurocognitive test battery in tested and propensity score matched 
post-heart surgery population and healthy controls in the LGC trial (continued) 
 
Tested population Propensity score matched population 
  Tested-Post-
Cardiac surgery 
population  
(N=361) 
Healthy controls  
 
(N=215) 
p-value Tested-Post-
Cardiac surgery 
population  
(N=167) 
Healthy controls  
 
(N=167) 
p-value 
Memory2       
-Verbal-auditory       
   Numbers (range, 1-19): Memory span 
   (forward) 
8 (5-9) 9 (7-11) <0.001 8 (6-11) 9 (7-11) 0.149 
   Numbers (range, 1-19): Working memory  
   (backward) 
9 (6-11) 10 (8-13) <0.001 9.5 (6.2-12) 10.5 (9-13) 0.003 
   Word pairs (proportion of correct 
   responses): Learning 
0.45 (0.33-0.53) 0.5 (0.38-0.66) 0.001 0.46 (0.36-0.57) 0.46 (0.35-0.6) 0.627 
   Word pairs (proportion of correct  
   responses): Immediate memory 
0.4 (0.2-0.5) 0.5 (0.35-0.64) <0.001 0.4 (0.23-0.5) 0.5 (0.3-0.6) 0.012 
   Word pairs (proportion of correct  
   responses): Delayed memory 
0.3 (0.2-0.4) 0.4 (0.3-0.5) <0.001 0.35 (0.21-0.42) 0.4 (0.28-0.5) 0.068 
   Word pairs (proportion of correct  
   responses): Recognition 
0.96 (0.9-1) 1 (0.95-1) 0.011 0.97 (0.9-1) 0.97 (0.93-1) 0.404 
-Nonverbal, visual-spatial  
  (proportion of correct responses) 
      
   Pictures: Memory span 0.83 (0.71-0.89) 0.89 (0.8-0.93) <0.001 0.84 (0.73-0.9) 0.86 (0.76-0.93) 0.114 
   Dots: learning 0.83 (0.66-0.88) 0.88 (0.83-0.94) <0.001 0.87 (0.70-0.94) 0.88 (0.80-0.94) 0.061 
   Dots: Immediate memory 0.83 (0.62-1) 1 (0.75-1) <0.001 0.87 (0.66-1) 1 (0.68-1) 0.224 
   Dots: delayed memory 0.83 (0.5-1) 1 (0.75-1) <0.001 0.83 (0.66-1) 0.87 (0.68-1) 0.268 
   Learning index (range, 50-150) 93 (84-103) 101 (90-109) <0.001 96 (87-103) 99 (87-109) 0.102 
Behavior (by proxy), T-score1       
 CBCL-internalizing problems (range,  
 29-100) 
52 (45-61) 48 (41-57) <0.001 51 (43-59) 49 (41-58) 0.046 
 CBCL-externalizing problems (range,  
 28-100) 
50 (43-56) 46 (40-55) 0.006 49 (41-55) 47 (40-56) 0.221 
 CBCL-total problems (range, 24-100) 52 (45-59) 47 (40-55) <0.001 51 (43-56) 48 (40-56) 0.049 
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median (interquartile range, IQR) are reported; 1Higher scores reflect worse performance; 
2Higher scores reflect better performance 
Abbreviations: SD = standard deviation; CBCL = Child Behavior Checklist  
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Legends of figures 
Figure 1. Flow diagram of Preferred Reporting Items for Systematic Reviews and Meta-
analyses (PRISMA)  
1Search strategy in eMethods 1 
2Manuscripts could be excluded for more than one reason 
 
Figure 2. Forest plot of intelligence  (author/year/journal – CHD-type) 
Abbreviations: TGA = d-transposition of the great arteries; VSD = ventricular septal defect; 
TOF = tetralogy of Fallot; ASD = atrial septal defect; ECMO = extracorporeal membrane 
oxygenation; V.d.Rijken = Van der Rijken; cath = catheterization; surg = surgery; CA = 
circulatory arrest; CPB = cardiopulmonary bypass; CI = confidence interval 
 
Figure 3. Forest plot of attention (Att) (alertness) non-reaction time (author/year/journal – 
CHD-type / attention measure) 
Legend: Att1 = Mean accuracy (%) Attention Network Test; Att2 = Visual Attention 
(NEuroPSYchological Assessment, NEPSY); Att3 = Auditory Attention (NEPSY); Att4 = 
Processing Speed (Wechsler Intelligence Scale for Children, WISC-IV); Att5 = Delay Task, 
Vigilance hits; Att6 = speed of information (BAS, British Ability Scales) 
 
Figure 4. Forest plot of verbal memory (Mem) (author/year/journal – CHD-type / Memory 
measure) 
Abbreviations: Mem1 = Sum of Immediate and Delayed Verbal Memory (Children's Memory 
Scale, Word Pairs, proportion correct responses); Mem2 = Narrative Memory (NEPSY); 
Mem3 = Verbal Memory (Wide Range Assessment of Memory and Learning, WRAML) 
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Figure 5. Forest plot of executive function (EF) (inhibition) reaction time (RT) 
(author/year/journal – CHD-type / EF measure) 
Abbreviations: EF-Test1 = Incongruent Stroop; EF-test2 = Stroop; EF-test3 = Conflict 
(Attention Network Test); EF-test4 = Inhibition (Amsterdam Neuropsychological Tasks) 
 
 
 
 
 
 
